We continually strive to reduce our impact on natural systems and the environment, with a focus on energy, greenhouse gases, water and waste. To achieve our goals, we have set specific environmental targets based on the reported values for full year 2018, until 2030.

2030 Targets and 2023 Progress

Base year 2018, total Company (Per CHF 1 Million Sales)

The targets also reflect our diverse and evolving product portfolio, which includes the manufacturing of pharmaceutical ingredients, medical capsules, food supplements, gene therapy and cell media, and the licensing of technologies and systems.

With a long-term view to 2030, we want to reduce consumption considerably to align with the broadly accepted greenhouse gas reduction targets, with an ambition of reaching net-zero greenhouse gas (GHG) emissions by 2050. Therefore in 2023, as part of our emission reduction strategy, we have submitted a letter of commitment to the Science-Based Targets initiative (SBTi) with plans to reduce absolute scope 1 and 2 GHG emissions by more than 40% by the end of 2030 (from a 2021 base year). Our targets were approved by the SBTi in early 2024.

Our Focus Areas